ag 112 has been researched along with 2-methyl-5-(4-methylanilino)-1,3-benzothiazole-4,7-dione in 1 studies
Studies (ag 112) | Trials (ag 112) | Recent Studies (post-2010) (ag 112) | Studies (2-methyl-5-(4-methylanilino)-1,3-benzothiazole-4,7-dione) | Trials (2-methyl-5-(4-methylanilino)-1,3-benzothiazole-4,7-dione) | Recent Studies (post-2010) (2-methyl-5-(4-methylanilino)-1,3-benzothiazole-4,7-dione) |
---|---|---|---|---|---|
19 | 0 | 10 | 9 | 0 | 6 |
Protein | Taxonomy | ag 112 (IC50) | 2-methyl-5-(4-methylanilino)-1,3-benzothiazole-4,7-dione (IC50) |
---|---|---|---|
Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | 0.39 | |
Cyclin-dependent kinase 4 | Homo sapiens (human) | 7.1667 | |
G1/S-specific cyclin-D1 | Homo sapiens (human) | 7.75 | |
N-lysine methyltransferase KMT5A | Homo sapiens (human) | 0.435 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Augustin, M; Davies, SP; Gao, Y; Harvey, KJ; Kovelman, R; Patel, UA; Woodward, A | 1 |
1 other study(ies) available for ag 112 and 2-methyl-5-(4-methylanilino)-1,3-benzothiazole-4,7-dione
Article | Year |
---|---|
A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery.
Topics: Aurora Kinases; Cluster Analysis; Drug Design; Drug Discovery; Drug Evaluation, Preclinical; ErbB Receptors; Humans; Intracellular Signaling Peptides and Proteins; MAP Kinase Kinase 4; p38 Mitogen-Activated Protein Kinases; Protein Kinase Inhibitors; Protein Kinases; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Receptors, Vascular Endothelial Growth Factor; Recombinant Proteins; Reproducibility of Results; Signal Transduction; Small Molecule Libraries; Structure-Activity Relationship; Syk Kinase | 2013 |